The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Healthcare Realty Trust Inc

NYSE: HR
Last

(U.S.) $33.32

Today's change+0.07 +0.21%
Updated April 27 4:02 PM EDT. Delayed by at least 15 minutes.
 

Healthcare Realty Trust Inc

NYSE: HR
Last

(U.S.) $33.32

Today's change+0.07 +0.21%
Updated April 27 4:02 PM EDT. Delayed by at least 15 minutes.

Healthcare Realty Trust Inc up (U.S.)$0.07

Healthcare Realty Trust Inc closed up Thursday by (U.S.)$0.07 or 0.21% to (U.S.)$33.32. Shares have lost 1.91% over the last five days, but have gained 9.89% over the last year to date. This security has underperformed the S&P 500 by 4.84% during the last year.

Key company metrics

  • Open(U.S.) $33.29
  • Previous close(U.S.) $33.25
  • High(U.S.) $33.54
  • Low(U.S.) $33.09
  • Bid / Ask-- / --
  • YTD % change+9.89%
  • Volume469,705
  • Average volume (10-day)511,234
  • Average volume (1-month)604,425
  • Average volume (3-month)601,997
  • 52-week range(U.S.) $26.66 to (U.S.) $36.60
  • Beta0.30
  • Trailing P/E43.60×
  • P/E 1 year forward68.66×
  • Forward PEG17.16×
  • Indicated annual dividend(U.S.) $1.20
  • Dividend yield3.60%
  • Trailing EPS(U.S.) $0.76
Updated April 27 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+20.83%

Based on its net profit margin of 20.83%, Healthcare Realty Trust Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.91%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue105104103100
Total other revenue--------
Total revenue105104103100
Gross profit68666665
Total cost of revenue37383635
Total operating expense80787676
Selling / general / administrative99810
Research & development--------
Depreciation / amortization34323130
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income25252724
Interest income (expense), net non-operating-14-14-15-15
Gain (loss) on sale of assets4100--
Other--------
Income before tax5312129
Income after tax5312129
Income tax, total--------
Net income5212129
Total adjustments to net income--------
Net income before extra. items5312129
Minority interest0------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5312129
Inc. avail. to common incl. extra. items5212129
Diluted net income5212129
Dilution adjustment--------
Diluted weighted average shares115115105102
Diluted EPS excluding extraordinary itemsvalue per share0.460.100.120.09
Dividends per sharevalue per share0.300.300.300.30
Diluted normalized EPSvalue per share0.380.100.120.09